Table 2.
Number of patients
|
RTI episodes
|
SD
|
p-value | ||||
---|---|---|---|---|---|---|---|
Oscillococcinum | Control | Oscillococcinum | Control | Oscillococcinum | Control | ||
RRI | |||||||
All patients | 88 | 19 | 1.02 | 2.58 | 0.84 | 1.05 | <0.0001 |
Pediatric patients | 88 | 19 | 1.02 | 2.58 | 0.84 | 1.05 | <0.0001 |
RTI | |||||||
All patients | 43 | 71 | 0.31 | 0.81 | 0.40 | 0.66 | <0.0001 |
Pediatric patients | 2 | 23 | 0.30 | 1.09 | 0.11 | 0.65 | 0.0496 |
ARD | |||||||
All patients | 24 | 41 | 0.24 | 1.05 | 0.35 | 0.85 | <0.0001 |
Pediatric patients | 2 | 12 | 0.23 | 1.68 | 0.14 | 0.94 | 0.0271 |
Asthma | |||||||
All patients | 55 | 47 | 0.42 | 1.01 | 0.37 | 0.63 | <0.0001 |
Pediatric patients | 15 | 8 | 0.59 | 1.31 | 0.37 | 0.82 | 0.0079 |
COPD | |||||||
All patients | 36 | 31 | 0.87 | 1.57 | 0.38 | 0.66 | <0.0001 |
Pediatric patients | 0 | 0 | 0.00 | 0.00 |
Note: Oscillococcinum® manufactured by Boiron, Messimy, France.
Abbreviations: RRI, recurrent respiratory infection; RTI, respiratory tract infection; ARD, allergic respiratory disease; SD, standard deviation.